Q4 2018 Investor Presentation

> Track Record of Disciplined Financial Growth Revenue ($B) Adjusted EPS $1.5 2013 9% CAGR $2.3 Fiscal Years ended June 30 © 2018 ResMed | Q4 2018 Investor Presentation | 33 $2.27 Quarterly dividend 9% CAGR $3.53 16% CAGR $0.35 $0.17 2018 2013 2018 2013 2018 ResMed

View entire presentation